1887

Abstract

The technique of depletion with T cell subset-specific monoclonal antibodies was used to study the involvement of CD8 T cells in protection/pathogenesis during the acute and chronic demyelinating phases of Theiler’s murine encephalomyelitis virus (TMEV)-induced disease. Mice rendered CD8-deficient prior to infection with TMEV were less efficient at clearing virus from the central nervous system compared to intact animals and also suffered demyelinating disease of earlier onset and increased severity. This indicates that CD8 cells have a protective role in virus clearance at early times post-infection, and may also be involved in downregulating the severity of the chronic demyelinating disease. How CD8 T cells function to produce these effects is discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-7-1861
1992-07-01
2021-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/7/JV0730071861.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-7-1861&mimeType=html&fmt=ahah

References

  1. Aubert C., Chamorrow M., Brahic M. 1987; Identification of Theiler’s virus infected cells in the central nervous system of the mouse during demyelinating disease. Microbial Pathogenesis 3:319–326
    [Google Scholar]
  2. Blakemore W. F., Welsh C. J. R., Tonks P., Nash A. A. 1988; Observations on demyelinating lesions induced by Theiler’s virus in CBA mice. Acta neuropathologica 76:581–589
    [Google Scholar]
  3. Brahic M., Stroop W. G., Baringer J. R. 1981; Theiler’s virus persists in glial cells during demyelinating disease. Cell 26:123–128
    [Google Scholar]
  4. Clatch R. J., Melvold R. W., Miller S. D., Lipton H. L. 1985; Theiler’s murine encephalomyelitis virus-induced demyelinating disease in mice is influenced by the H.2D regions: correlation with TMEV-specific delayed-type hypersensitivity. Journal of Immunology 135:1408–1414
    [Google Scholar]
  5. Clatch R. J., Lipton H. L., Miller S. D. 1987a; Class II-restricted T cell responses in Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and CNS virus titres in inbred mouse strains. Microbial Pathogenesis 3:327–337
    [Google Scholar]
  6. Clatch R. J., Melvold R. W., Dal Canto M. C., Miller S. D., Lipton H. L. 1987b; The Theiler’s murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B and C. Journal of Neuroimmunology 15:121–135
    [Google Scholar]
  7. Cobbold S. P., Jayasuriya A., Nash A. A., Prospero T. D., Waldmann H. 1984; Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature, London 312:548–551
    [Google Scholar]
  8. Cobbold S. P., Martin G., Qin S., Waldmann H. 1986; Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature, London 332:164–166
    [Google Scholar]
  9. Dal Canto M. C., Lipton H. L. 1975; Primary demyelination in Theiler’s virus infection: an ultrastructural study. Laboratory Investigation 33:626–637
    [Google Scholar]
  10. Friedmann A., Frankel G., Lorch Y., Steinman L. 1987; Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler’s virus-infected mice: critical importance of time of treatment. Journal of Virology 61:898–903
    [Google Scholar]
  11. Lindsley M. D., Thiemann R., Rodriguez M. 1991; Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler’s virus. Journal of Virology 65:6612–6620
    [Google Scholar]
  12. Lipton H. L. 1975; Theiler’s virus infection in mice: an unusual biphasic disease process leading to demyelination. Infection and Immunity 11:1147–1155
    [Google Scholar]
  13. Lipton H. L. 1980; Persistent Theiler’s murine encephalomyelitis virus infection in mice depends on plaque size. Journal of General Virology 46:169–177
    [Google Scholar]
  14. Lipton H. L., Dal Canto M. C. 1976; Theiler’s virus-induced demyelination: prevention by immunosuppression. Science 192:62–64
    [Google Scholar]
  15. Lipton H. L., Dal Canto M. C. 1977; Contrasting effects of immunosuppression on Theiler’s virus infection in mice. Infection and Immunity 15:903–909
    [Google Scholar]
  16. Lipton H. L., Melvold R. 1984; Genetic analysis of susceptibility to Theiler’s virus-induced demyelinating disease in mice. Journal of Immunology 132:1821–1825
    [Google Scholar]
  17. Nash A. A., Jayasuriya A., Phelan J., Cobbold S. P., Waldmann H., Prospero T. 1987; Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68:825–833
    [Google Scholar]
  18. Rodriguez M., David C. S. 1985; Demyelination induced by Theiler’s virus: influence of the H-2 haplotype. Journal of Immunology 135:2145–2148
    [Google Scholar]
  19. Rodriguez M., Sriram S. 1988; Successful therapy of Theiler’s virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. Journal of Immunology 140:2950–2955
    [Google Scholar]
  20. Rodriguez M., Leibowitz J. L., Lampert P. W. 1983; Persistent infection of oligodenrocytes in Theiler’s virus-induced encephalomyelitis. Annals of Neurology 13:426–433
    [Google Scholar]
  21. Rodriguez M., Lafuse W. P., Leibowitz J., David C. S. 1986a; Partial suppression of Theiler’s virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (la antigens). Neurology 36:964–970
    [Google Scholar]
  22. Rodriguez M., Leibowitz J., David C. S. 1986b; Susceptibility to Theiler’s virus-induced demyelination. Mapping of the gene within the H-2D region. Journal of Experimental Medicine 163:620–631
    [Google Scholar]
  23. Roos R. P., Firestone S., Wollman R., Variakojis D., Arnason B. G. W. 1982; The effect of short-term and chronic immunesuppression on Theiler’s virus demyelination. Journal of Neuroimmunology 2:223–234
    [Google Scholar]
  24. Rossi C. P., McAllister A., Fiette L., Brahic M. 1991; Theiler’s virus infection induces a specific cytotoxic T lymphocyte response. Cellular Immunology 138:341–348
    [Google Scholar]
  25. Rueckert R. R., Pallansch M. A. 1981; Preparation and characterization of encephalomyocarditis (EMC) virus. Methods in Enzymology 78:315–325
    [Google Scholar]
  26. Sriram S., Caroll L., Fortin S., Cooper S., Ranges G. 1988; In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis. Journal of Immunology 141:464–468
    [Google Scholar]
  27. Welsh C. J. R., Tonks P., Nash A. A., Blakemore W. F. 1987; The effect of L3T4 T cell depletion on the pathogenesis of Theiler’s murine encephalomyelitis virus infection in CBA mice. Journal of General Virology 68:1659–1667
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-7-1861
Loading
/content/journal/jgv/10.1099/0022-1317-73-7-1861
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error